$ITOC

iTonic Holdings Ltd

iTonic Holdings is a Cayman Islands holding company with no material operations of its own. Its business is conducted through Beijing Feitian, a healthcare solutions provider in China, while its recently acquired U.S. subsidiary, iTonic Corporation, is a development-stage entity. Beijing Feitian develops and commercializes FTTPS, software for planning brachytherapy treatment using radioactive particle implants in cancer patients. Hospitals use the system to plan, adjust and verify treatment. Beijing Feitian also sells Medical Auxiliary Supplies, including printed 3D molds, seed implant needles, workstations and patient positioning devices, to hospitals, hospital procurement providers and individual cancer patients. The business earns money from sales of FTTPS and Medical Auxiliary Supplies. iTonic Corporation is developing a proposed operating system for intergenerational home care that would integrate AI, medical device automation and clinical expertise; its planned component SAVi is a voice-enabled health companion. iTonic Holdings’ principal executive offices are in Beijing, China.

No enriched coverage for $ITOC in the last 7 days.

No SEC Form 4 filings for $ITOC in the last 30 days.

See all $ITOC insider activity →
Low

iTonic Holdings regains Nasdaq minimum bid price compliance

iTonic Holdings (ITOC) has regained compliance with Nasdaq's minimum bid price requirement, maintaining a closing bid price of at least $1.00 per share for ten consecutive days. The company received a deficiency notice in 2025 and was granted an extension to October 19. iTonic implemented a 16-for-1 share consolidation on October 6. The company focuses on digital medical technologies and AI investments in healthcare.

iTonic Holdings Ltd Announces 16-for-1 Share Consolidation Effective October 6, 2026

iTonic Holdings Ltd (Nasdaq: ITOC) announced a 16-for-1 share consolidation, reducing its Class A and B shares from 109,382,000 and 7,668,000 to 6,836,375 and 479,250, respectively. The consolidation, effective October 6, 2026, aims to boost the share price to meet Nasdaq's $1.00 minimum bid requirement. The company has until October 19, 2026, to comply.

ITOC sentiment & insider activity

What's driving ITOC

AlphAI scores every news story that mentions ITOC with an AI model for sentiment and relevance, and aggregates insider trades from iTonic Holdings Ltd's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $ITOC

Score

iTonic Holdings regains Nasdaq minimum bid price compliance

iTonic Holdings (ITOC) has regained compliance with Nasdaq's minimum bid price requirement, maintaining a closing bid price of at least $1.00 per share for ten consecutive days. The company received a deficiency notice in 2025 and was granted an extension to October 19. iTonic implemented a 16-for-1 share consolidation on October 6. The company focuses on digital medical technologies and AI investments in healthcare.

iTonic Holdings Ltd Announces 16-for-1 Share Consolidation Effective October 6, 2026

iTonic Holdings Ltd (Nasdaq: ITOC) announced a 16-for-1 share consolidation, reducing its Class A and B shares from 109,382,000 and 7,668,000 to 6,836,375 and 479,250, respectively. The consolidation, effective October 6, 2026, aims to boost the share price to meet Nasdaq's $1.00 minimum bid requirement. The company has until October 19, 2026, to comply.

Related tickers